Literature DB >> 31758701

IL-1-dependent electrophysiological changes and cardiac neural remodeling in a mouse model of Kawasaki disease vasculitis.

M Abe1, D D Rastelli1,2, A C Gomez1, E Cingolani3, Y Lee1, P R Soni1, M C Fishbein4, T J A Lehman5, K Shimada1,6, T R Crother1,6, S Chen1,6, M Noval Rivas1,6, M Arditi1,3,6.   

Abstract

Kawasaki disease (KD) is the leading cause of acquired heart disease in children. In addition to coronary artery abnormalities, aneurysms and myocarditis, acute KD is also associated with echocardiogram (ECG) abnormalities in 40-80% of patients. Here, we show that these ECG changes are recapitulated in the Lactobacillus casei cell wall extract (LCWE)-induced KD vasculitis mouse model. LCWE-injected mice developed elevated heart rate and decreased R wave amplitude, with significant differences in prolonged ventricular repolarization. LCWE-injected mice developed cardiac ganglion inflammation, that may affect the impulse-conducting system in the myocardium. Furthermore, serum nerve growth factor (NGF) was significantly elevated in LCWE-injected mice, similar to children with KD vasculitis, associated with increased neural remodeling of the myocardium. ECG abnormalities were prevented by blocking interleukin (IL)-1 signaling with anakinra, and the increase in serum NGF and cardiac neural remodeling were similarly blocked in Il1r1-/- mice and in wild-type mice treated with anakinra. Thus, similar to clinical KD, the LCWE-induced KD vasculitis mouse model also exhibits electrophysiological abnormalities and cardiac neuronal remodeling, and these changes can be prevented by blocking IL-1 signaling. These data support the acceleration of anti-IL-1 therapy trials to benefit KD patients.
© 2019 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31758701      PMCID: PMC7008220          DOI: 10.1111/cei.13401

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  62 in total

1.  Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version.

Authors: 
Journal:  Circ J       Date:  2010-08-18       Impact factor: 2.993

Review 2.  Finding the cause of Kawasaki disease: a pediatric infectious diseases research priority.

Authors:  Anne H Rowley
Journal:  J Infect Dis       Date:  2006-11-02       Impact factor: 5.226

Review 3.  Misinterpretation of the mouse ECG: 'musing the waves of Mus musculus'.

Authors:  Bastiaan J Boukens; Mathilde R Rivaud; Stacey Rentschler; Ruben Coronel
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

4.  An evaluation of the validity of the animal models of Kawasaki disease vasculopathy.

Authors:  Jan M Orenstein; Anne H Rowley
Journal:  Ultrastruct Pathol       Date:  2014-08       Impact factor: 1.094

5.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).

Authors:  Adriana H Tremoulet; Sonia Jain; Susan Kim; Jane Newburger; Moshe Arditi; Alessandra Franco; Brookie Best; Jane C Burns
Journal:  Contemp Clin Trials       Date:  2016-04-11       Impact factor: 2.226

6.  CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.

Authors:  Magali Noval Rivas; Youngho Lee; Daiko Wakita; Norika Chiba; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Michael C Fishbein; Thomas J A Lehman; Timothy R Crother; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

7.  Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization.

Authors:  C S Kuo; C P Reddy; K Munakata; B Surawicz
Journal:  Eur Heart J       Date:  1985-11       Impact factor: 29.983

Review 8.  Is Kawasaki disease an infectious disorder?

Authors:  Anne H Rowley
Journal:  Int J Rheum Dis       Date:  2017-11-03       Impact factor: 2.454

9.  Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.

Authors:  D Y Leung; R S Cotran; E Kurt-Jones; J C Burns; J W Newburger; J S Pober
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

10.  IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.

Authors:  M Gorelik; Y Lee; M Abe; T Andrews; L Davis; J Patterson; S Chen; T R Crother; G J Aune; M Noval Rivas; M Arditi
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

View more
  2 in total

Review 1.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

Review 2.  Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Tiphanie P Vogel; Karina A Top; Christos Karatzios; David C Hilmers; Lorena I Tapia; Pamela Moceri; Lisa Giovannini-Chami; Nicholas Wood; Rebecca E Chandler; Nicola P Klein; Elizabeth P Schlaudecker; M Cecilia Poli; Eyal Muscal; Flor M Munoz
Journal:  Vaccine       Date:  2021-02-25       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.